| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jul 8, 2021 | Jul 9, 2021 | Evofem Biosciences, Inc. | Chief Commercial Officer | Sell | 46.3 | -19,998 | -4.27% | ✗ | $19.5K |
| Jun 11, 2021 | Jun 11, 2021 | Evofem Biosciences, Inc. | Chief Commercial Officer | Buy | 83.8 | +18,180 | 4.03% | ✗ | $20.7K |
| May 20, 2021 | May 21, 2021 | Evofem Biosciences, Inc. | Chief Commercial Officer | Sell | 46.3 | -31,480 | -6.53% | ✗ | $27.1K |
| Sep 10, 2020 | Sep 11, 2020 | Evofem Biosciences, Inc. | Chief Commercial Officer | Buy | 77.5 | +4,000 | 1.45% | ✗ | $9K |
| Jul 8, 2020 | Jul 9, 2020 | Evofem Biosciences, Inc. | Chief Commercial Officer | Sell | 42.5 | -20,381 | -6.89% | ✗ | $67.3K |
| Jun 5, 2020 | Jun 8, 2020 | Evofem Biosciences, Inc. | Chief Commercial Officer | Sell | 42.5 | -15,455 | -5.00% | ✗ | $51.2K |
| May 22, 2020 | May 26, 2020 | Evofem Biosciences, Inc. | Chief Commercial Officer | Sell | 42.5 | -19,474 | -5.92% | ✗ | $97.2K |
| May 6, 2020 | May 8, 2020 | Evofem Biosciences, Inc. | Chief Commercial Officer | Sell | 46.3 | -3,802 | -1.14% | ✗ | $19.9K |
| Feb 19, 2020 | Feb 21, 2020 | Evofem Biosciences, Inc. | Chief Commercial Officer | Sell | 37.5 | -14,957 | -4.30% | ✓ | $97.2K |
| Jan 16, 2020 | Jan 21, 2020 | Evofem Biosciences, Inc. | Chief Commercial Officer | Sell | 51.3 | -1,578 | -0.80% | ✓ | $10.3K |
| Nov 25, 2019 | Nov 26, 2019 | Evofem Biosciences, Inc. | Chief Commercial Officer | Sell | 42.5 | -9,277 | -4.47% | ✗ | $57.7K |
| Nov 20, 2019 | Nov 21, 2019 | Evofem Biosciences, Inc. | Chief Commercial Officer | Sell | 42.5 | -9,044 | -4.18% | ✗ | $51.9K |
| Aug 22, 2019 | Aug 26, 2019 | Evofem Biosciences, Inc. | Chief Commercial Officer | Sell | 52.5 | -962 | -0.44% | ✗ | $4.9K |
| Jul 8, 2019 | Jul 10, 2019 | Evofem Biosciences, Inc. | Chief Commercial Officer | Sell | 95.0 | +136,743 | 169.46% | ✗ | $66.2K |
| Jun 10, 2019 | Jun 12, 2019 | Evofem Biosciences, Inc. | Chief Commercial Officer | Sell | 46.3 | -5,965 | -6.88% | ✗ | $37.9K |
| Apr 1, 2019 | Apr 3, 2019 | Evofem Biosciences, Inc. | Chief Commercial Officer | Sell | 47.5 | -1,160 | -1.32% | ✗ | $4.1K |
| Nov 21, 2018 | Nov 26, 2018 | Evofem Biosciences, Inc. | Chief Commercial Officer | Buy | 77.5 | +279 | 2.22% | ✗ | $990.5 |
| Aug 10, 2018 | Aug 13, 2018 | Evofem Biosciences, Inc. | Chief Commercial Officer | Buy | 90.0 | +3,715 | 42.09% | ✗ | $7.4K |
| Jul 2, 2018 | Jul 3, 2018 | Evofem Biosciences, Inc. | Chief Commercial Officer | Sell | 90.0 | +8,826 | 100.00% | ✗ | $7K |